Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd (NASDAQ: CLBT) provides authoritative digital intelligence solutions to law enforcement and enterprises worldwide. This news hub offers investors and professionals a centralized resource for tracking corporate developments, technological advancements, and strategic initiatives shaping the digital forensics sector.
Access timely updates including earnings reports, product launches, partnership announcements, and regulatory filings. Our curated collection ensures stakeholders stay informed about critical developments affecting investigative technology markets, cybersecurity trends, and Cellebrite’s position as a leader in legally sanctioned data analysis solutions.
Key updates cover innovations in mobile device forensics, cloud data extraction tools, and enterprise-grade investigative platforms. Regular monitoring of this page provides insights into Cellebrite’s subscription revenue growth, global expansion efforts, and responses to evolving data privacy regulations.
Bookmark this page for structured access to CLBT’s official communications and third-party analysis. Combine technical understanding of digital intelligence markets with strategic business insights through our maintained news archive.
Cellebrite (NASDAQ: CLBT) has launched Cellebrite Federal Solutions to enhance its strategic relationship with the U.S. federal government. This move includes the acquisition of Cyber Technology Services, Inc. (CyTech), expanding Cellebrite's capabilities in cybersecurity and digital forensics. The new unit, led by Erik Sachwitz, aims to address the evolving needs of U.S. federal customers and unlock more opportunities.
Key highlights:
- Acquisition of CyTech to broaden Cellebrite's expertise
- Establishment of a dedicated unit for federal sector
- Appointment of four renowned independent directors
- Focus on AI-driven Case-to-Closure platform
- U.S. federal customers generated 19% of Cellebrite's annual recurring revenue in the public sector in 2023, up 21% from the previous year
Cellebrite (NASDAQ: CLBT), a leader in Digital Investigative solutions, will report its Q2 2024 financial results on August 15, 2024, before market open. A live conference call and webcast will follow at 8:30 a.m. ET to review the results and discuss the company's outlook for 2024. Investors can access the call via a designated call-in number or through a live webcast. Historical financial data and supplemental information will be available on Cellebrite's investor relations website. A replay and transcript of the call will also be accessible later.
Cellebrite, a leader in digital investigative solutions, announced the availability of its Endpoint Inspector SaaS on the AWS Marketplace. This solution, part of Cellebrite's Case-to-Closure platform, allows corporate investigators and eDiscovery practitioners to collect and analyze data in real-time from various remote devices. Utilizing AWS cloud infrastructure, Endpoint Inspector SaaS enhances data extraction speed and insight depth for corporate investigations, such as fraud and intellectual property theft. It supports hybrid work environments, enabling secure, consent-based data collection without the need for physical device access. AWS Marketplace facilitates easy deployment, automated billing, and payment tracking.
Leopard Asset Management (LAM) is calling on Sun shareholders to hold the company's management accountable for failing to increase shareholder value. LAM has highlighted Sun's undervaluation, primarily due to its significant holdings in Cellebrite (NASDAQ: CLBT), and other liquid assets.
Since LAM's campaign in March 2024, Sun's share price briefly increased by 23% but fell by 19% after a disappointing AGM agenda was released, indicating a lack of trust in management.
LAM urges shareholders to vote against CEO Ryusuke Utsumi and his team in the upcoming June 25 AGM, citing management's failure to take meaningful action to close the valuation gap.
Sun's shares are valued at ¥7,200 based on liquid assets, far above the current market price of ¥3,300, emphasizing the need for a change in leadership to realize the company's true value.
Cellebrite (NASDAQ: CLBT) announced its Q1 2024 results, reporting a 27% year-over-year increase in Annual Recurring Revenue (ARR) to $331.8 million. Q1 2024 revenue rose by 26% to $89.6 million, driven by a 29% growth in subscription revenue. The company recorded a GAAP net loss of $71.4 million and a non-GAAP net income of $16.9 million. Adjusted EBITDA stood at $17.6 million with a 19.7% margin. CEO Yossi Carmil emphasized the global expansion and profitability improvements, noting the positive reception of new products like the Inseyets digital forensics software. The company reaffirmed its outlook for 2024, expecting ARR between $380 million and $400 million, and revenue between $370 million and $380 million for the full year.
Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, announced its participation in several investor conferences from May 26 to June 5, 2024. The company will engage in various formats, including fireside chats, 1x1 meetings, and presentations.
Key dates include May 26 at the Oppenheimer 25th Annual Israeli Conference, May 29 at the Craig-Hallum Institutional Investor Conference, May 30 at the TD Cowen 52nd Annual Technology, Media & Telecom Conference, and June 5 at the William Blair 44th Annual Growth Stock Conference.
Cellebrite executives like Dana Gerner (CFO), Andrew Kramer (VP), and Yossi Carmil (CEO) will present at these events. The conferences are opportunities for the company to highlight its digital investigative solutions and connect with investors.
FAQ
What is the current stock price of Cellebrite Di (CLBT)?
What is the market cap of Cellebrite Di (CLBT)?
